KFDA rejects approval of Hanmi's sibutramine mesylate

The Korea Food and Drug Administration reacted negatively toward the approval of Hanmi's first generic version of Slimer capsule (sibutramine mesylate), first generic version of Reductil (sibutramine hydrochloride), a type of anti-obesity medicine, saying that the original product has been under re-examination, which will last until July 2007.

The administration further noted that Hanmi will...